Indications : התוויות

Therapeutic indications                                                                                       Activated clotting time                             Chromogenic factor Xa assay
Coagulation based factor Xa tests                   Functional (chromogenic) factor X assay VIBATIV is indicated for the treatment of adults with nosocomial pneumonia (NP) including ventilator                                                                  Bleeding time associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus                                                                         D-dimer aureus (MRSA).                                                                                                                                                        Fibrin degradation products VIBATIV should be used only in situations where it is known or suspected that other alternatives are not suitable (see sections 4.3, 4.4, 4.8 and 5.1).                                                                   No evidence of increased bleeding risk has been observed in clinical trials with telavancin. Telavancin Consideration should be given to official guidance on the appropriate use of antibacterial agents.               has no effect on platelet aggregation. Furthermore, no evidence of hypercoagulability has been seen, as healthy subjects receiving telavancin have normal levels of D-dimer and fibrin degradation products.